Name | Type | Posted | Actions |
|---|---|---|---|
36C25626Q0533.docx | DOCX | Mar 20, 2026 |
Q517--667-27-1-075-0004- Compounding sterile hazardous chemotherapy agents
Contact and place of performance
Tiffany Conner
Not specified
This is a SOURCES SOUGHT NOTICE ONLY This SOURCE SOUGHT NOTICE is for the purpose of Market Research. Response to this notice will be used for information and planning purposes. No proposals or quotes are being requested or accepted with this notice. THIS IS NOT A SOLICITATION FOR PROPOSALS or QUOTES and NO CONTRACT SHALL BE AWARDED FROM THIS NOTICE. This notice shall NOT be construed as solicitation or as an obligat...
View moreThe Department of Veterans Affairs, Network Contracting Office (NCO) 16, has issued this special notice to conduct market research for sterile compounding services. This sources sought notice is intended to identify capable providers, specifically targeting Service-Disabled Veteran Owned Small Businesses, Veteran Owned Small Businesses, or Small Businesses. The requirement serves as a compounding contingency plan for the Southeast Louisiana Veterans Healthcare System in New Orleans, Louisiana, to ensure the availability of pharmaceutical treatments for veterans. The government has classified this requirement under NAICS 456110 Pharmacies and Drug Retailers and PSC Q517 Medical- Pharmacology.
The selected contractor will provide non-personal services for the aseptic compounding of chemotherapy agents and patient-specific orders, including necessary IV tubing and closed-system drug-transfer devices. Compounding must occur at an FDA 503A compliant facility and adhere to USP 797, USP 800, and all federal and state laws. Orders submitted by 12:00 p.m. CST must be delivered to the New Orleans VA inpatient pharmacy by 9:00 a.m. CST the following day. The scope includes maintaining contingency backup plans for equipment malfunctions or natural disasters and providing annual certification reports for sterile compounding areas.
The anticipated period of performance consists of a one-year base period starting from the date of award, with four optional one-year extensions. Responses to this notice must include a capability statement and are due by 12:00 p.m. Central Standard Time on April 6, 2026. Submissions should be directed to Tiffany Conner via email. One attachment, a document titled 36C25626Q0533.docx, was published with the notice on March 20, 2026. This notice is for information and planning purposes only and does not constitute a solicitation or a contract award.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.